VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 487 filers reported holding VALEANT PHARMACEUTICALS INTL in Q2 2014. The put-call ratio across all filers is 0.91 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $6,386,000 | -61.5% | 62,825 | -32.4% | 0.92% | -58.4% |
| Q3 2015 | $16,575,000 | -21.7% | 92,920 | -2.5% | 2.22% | -9.9% |
| Q2 2015 | $21,169,000 | +32467.7% | 95,290 | +29220.0% | 2.47% | +35185.7% |
| Q1 2015 | $65,000 | -99.6% | 325 | -99.7% | 0.01% | -99.7% |
| Q4 2014 | $17,569,000 | +53139.4% | 122,768 | +49403.2% | 2.06% | +51450.0% |
| Q3 2014 | $33,000 | -99.3% | 248 | -99.4% | 0.00% | -99.5% |
| Q2 2014 | $5,034,000 | +27.6% | 39,918 | +33.4% | 0.82% | -8.1% |
| Q1 2014 | $3,944,000 | +20.4% | 29,918 | +7.3% | 0.89% | -15.4% |
| Q4 2013 | $3,275,000 | +146.4% | 27,895 | +119.0% | 1.06% | +45.1% |
| Q3 2013 | $1,329,000 | – | 12,736 | – | 0.73% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 5,701,010 | $1,266,479,000 | 36.57% |
| Ruane, Cunniff & Goldfarb | 33,884,050 | $7,527,342,000 | 35.90% |
| LeVasseur Capital Partners LLC | 188,804 | $41,943,000 | 34.97% |
| Pershing Square Capital Management | 19,473,933 | $4,326,134,000 | 29.95% |
| FARLEY CAPITAL L.P. | 141,020 | $31,328,000 | 24.16% |
| Ratan Capital Management LP | 1,038,033 | $230,599,000 | 21.97% |
| Marble Arch Investments | 1,069,000 | $237,478,000 | 20.47% |
| Arrow Capital Management, LLC | 144,461 | $32,092,000 | 18.04% |
| Tesuji Partners | 1,368,040 | $303,910,000 | 17.93% |
| ValueAct Holdings | 14,994,261 | $3,330,975,000 | 17.54% |